Hello, everyone, and how are you today? We are doing just splendidly, thank you, despite the icy frost that has descended on the Pharmalot campus. Our solution for such chilly moments is, not surprisingly, to fire up the coffee kettle and indulge ourselves with a few cups of stimulation. Our choice today is blueberry cobbler, should you need some inspiration. By the way, we apologize for the slow posting pace, but we are immersed in the final stages of a project. But we remain happy to receive saucy tips and secret dossiers. Meanwhile, here are some tidbits. Hope your day is productive.
The Trump administration is moving forward on a plan to allow the importation of cheaper drugs from Canada and other countries, a central plank of its plan to combat prescription costs, STAT writes. The Food and Drug Administration will announce a rule letting states develop plans to import certain prescription drugs from Canada. One rule would let states, wholesalers, or pharmacies apply to import certain drugs from Canada, pending a sign-off from the Department of Health and Human Services. A second would let drug makers import their own products sold in other countries.
About the Author Reprints
